Novavax Inc (NASDAQ:NVAX)

84.58
Delayed Data
As of Jan 21
 -5.78 / -6.40%
Today’s Change
84.55
Today|||52-Week Range
331.68
-40.88%
Year-to-Date
1 Green Flag for Novavax in 2022, and 1 Red Flag
6:00am / MotleyFool.com - Paid Partner Content
Why BioNTech, Moderna, Novavax, and Ocugen Stocks Are Plunging This Week
Jan 20 / MotleyFool.com - Paid Partner Content
The Worst Mistake Moderna Investors Can Make in 2022
Jan 22 / MotleyFool.com - Paid Partner Content
Could Novavax Go Parabolic?
Jan 19 / MotleyFool.com - Paid Partner Content
2 Growth Stocks That Could Take Off in February
Jan 21 / MotleyFool.com - Paid Partner Content
Why BioNTech, Moderna, and Novavax Stocks Are Sinking Today
Jan 18 / MotleyFool.com - Paid Partner Content
Edge Wealth Management LLC Buys SPDR Biotech ETF, Salesforce. ...
Jan 21 / GuruFocus News - Paid Partner Content
Here's Some Good News for Novavax That Investors Are Overlooking
Jan 18 / MotleyFool.com - Paid Partner Content
Why Novavax Stock Tumbled on Thursday
Jan 20 / MotleyFool.com - Paid Partner Content
10 Top Stocks That Can Make You Richer in 2022
Jan 18 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close90.36
Today’s open87.68
Day’s range84.55 - 90.91
Volume275,268
Average volume (3 months)5,699,516
Market cap$6.4B
Data as of 4:58pm ET, 01/21/2022

Growth & Valuation

Earnings growth (last year)-31.99%
Earnings growth (this year)-72.81%
Earnings growth (next 5 years)+2.00%
Revenue growth (last year)+2,448.48%
P/E ratioNM
Price/Sales13.49
Price/Book9.57

Competitors

----
NTLAIntellia Therapeutic...-1.02-1.23%
NBIXNeurocrine Bioscienc...+2.35+3.23%
ARWRArrowhead Pharmaceut...-1.66-3.16%
Data as of 4:00pm ET, 01/21/2022

Financials

Next reporting dateFebruary 28, 2022
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$475.6M
Annual profit (last year)-$418.3M
Net profit margin-87.94%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Gaithersburg, Maryland

Forecasts